Herpes Simplex Virus 2 ICP0− Mutant Viruses Are Avirulent and Immunogenic: Implications for a Genital Herpes Vaccine

ICP0 Antagonizes ICP4-Dependent Silencing of the Herpes Simplex Virus ICP0 Gene

(2010) Mingyu Liu et al.   PLoS One

ICP0 Dismantles Microtubule Networks in Herpes Simplex Virus-Infected Cells

(2010) Mingyu Liu et al.   PLoS One

Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein

(2010) Natalia J. Reszka et al.   VACCINE

Vaccinia virus vaccines: Past, present and future

(2009) Bertram L. Jacobs et al.   ANTIVIRAL RESEARCH

Psychosocial Well-Being and Quality of Life Among Women Newly Diagnosed With Genital Herpes

(2009) Hayley Mark et al.   JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING

The Safety Profile of Varicella Vaccine: A 10‐Year Review

(2008) Susan A. Galea et al.   JOURNAL OF INFECTIOUS DISEASES

Host Responses to Wild-Type and Attenuated Herpes Simplex Virus Infection in the Absence of Stat1

(2008) T. J. Pasieka et al.   JOURNAL OF VIROLOGY

Herpes Simplex Virus Type 1 ICP0 Phosphorylation Mutants Impair the E3 Ubiquitin Ligase Activity of ICP0 in a Cell Type-Dependent Manner

(2008) C. Boutell et al.   JOURNAL OF VIROLOGY

Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl5-29 and dl5-29-41L in mice and guinea pigs

(2008) Yo Hoshino et al.   VACCINE